managing patients with high-risk myeloma
Published 4 years ago • 140 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
1:25
the current approach to managing patients with prefibrotic pmf
-
5:19
the current treatment landscape for multiple myeloma and trials investigating novel combinations
-
2:15
the management of multiple myeloma in 2021
-
3:01
treatment approaches for asct-eligible myeloma patients in the frontline
-
3:24
novel agents for the management of r/r myeloma
-
2:16
current and future treatment approaches for hr-mds
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
3:56
the future of cancer treatment is here: introducing proton therapy
-
9:25
mgus diagnosis: a step-by-step approach
-
1:03:20
following & understanding your free light chain test results
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
2:20
ultra high-risk myeloma
-
2:17
extended follow-up of the master trial
-
2:33
the role of bispecific antibodies in the treatment of patients with multiple myeloma
-
3:42
the role of apobecs in myeloma & incorporating apobecs in current risk stratification models
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
3:29
current approaches and new approvals in mf and pv
-
0:51
challenges in managing myeloma patients
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
8:13
treatment strategies for high-risk mm
-
1:53
the future of multiple myeloma treatment